Adderall is a prescription medication (at least in the US) that is the brand name of a combination of amphetamine salts including dextroamphetamine and amphetamine.
This drug functions as a central nervous system stimulant for increased attention span, concentration and focus. Adderall RX has received FDA approval and is currently one of the most popular accepted forms of treatment for both childhood and adult ADHD.
It is also often used to help treat fatigue, especially in situations such as MS or sleep disorders such as narcolepsy in adults. It is also used illicitly as a smart drug and substance which can enhance energy.

- Focus longer, clear brain fog & feel more motivated
- Boost energy, alertnes & memory
- Contains 12 safe and natural nootropic ingredients
Adderall Introduction
Related Topics
- Best Brain Supplements
- What are Nootropics?
- Nootropics List
- How Do Nootropics Work?
- Natural Brain Boosters
- Brain Vitamins
- Increase your IQ
- How to Improve Concentration
- How to Improve Memory
- Focus Supplements
- Best ADHD Supplements
- Mood Enhancers
- Supplements for Anxiety
- Nootropics for Depression
- Best Brain Foods
- Does Brain Training Work?
- Brain Hacking
- Smart Drugs
- Cognitive Enhancement
In many cases, Adderall is used for “off-label” purposes as a wakefulness agent and a study pill.
However, there are a number of dangerous side effects associated with Adderall as well as serious risk of addiction, tolerance and withdrawal.
While Adderall abuse is certainly a risk, even at the doctor-recommended safe dosages there are frequent occurrences of adverse events. Concern is growing about the negative effects of Adderall among ADHD suffered and parents of children with ADHD.
Many individuals are turning to nootropics as safe and legal Adderall alternatives and replacements like Adrafinil that can improve brainpower without negatively impacting neuron function in the long term.
Adderall Effects:
Once Adderall is absorbed into the bloodstream, it then enters the central nervous system and is taken up by neurons in the brain. Then, the drug targets storage areas of the brain which hold neurotransmitters like Dopamine, Norepinephrine, and Adrenaline.
These hormones are also known as the catecholamines and form part of the body’s stress response system. They are typically released at times of great stress and excitement when you need additional energy and focus.
By artificially activating the adrenergic system, Adderall increases the release of these key neurotransmitters into your CNS. The result is a range of effects characteristic of amphetamine stimulants such as increased heart rate and blood pressure, higher energy levels and enhanced concentration, alertness and attention.
Adderall Benefits:
The primary benefit while using Adderall according to user reviews is mood elevation. This can even lead to mild euphoria in some users.
As a direct result of the increase in the levels of Dopamine, Serotonin, and Adrenaline, users will likely experience a change in their general brain chemistry. This can make people feel more attentive and focused.
Higher motivation and enhanced levels of productivity also are key benefits to this drug which is why it is so commonly prescribed to individuals with ADHD.
There is even some evidence to suggest that stimulation of this nature may lead to increases in the sizes of certain areas of the brain which are generally considered to help in the control of attention, motivation, and focus. Amphetamines like Adderall are also effective appetite suppressants and are sometimes used for off-label weight loss purposes.
Adderall Dosage:
The proper dosage of Adderall will be determined by a number of factors. These include the age of the person taking the product (i.e. child or adult) and the purpose for which it is being used.
Of course, it goes without saying that a qualified medical professional should be consulted before taking Adderall and it should be used under supervision of your doctor.
The generally recommended daily dosage for adults is between 5 and 60 mg. Take this drug in divided administrations throughout the day; begin upon awakening and use 1 to 2 additional administrations in 4 to 6 hour intervals.
Adderall Side Effects:
There is a lot of discussion and disagreement about the development of tolerance with Adderall. Some doctors think that if the dosage levels are kept to a minimum and the supplement is used on an as-needed basis than tolerance is really not a major issue, although they still do not usually discount the possibility.
However, it is a growing matter of concern in the medical community that it seems to take your body several days to fully recover and renormalize after using Adderall. Researchers have indicated that it takes the body time to restore its own natural production of the neurotransmitters which Adderall affects within the brain.
This may lead to receptor down regulation, adrenal fatigue or potential neurotoxicity by flooding the brain with too high levels of these excitatory neurotransmitters.
There are a few commonly reported Adderall side effects in adults. These include dry mouth, loss of appetite, difficulty falling asleep, and anxiety. This ADHD treatment is not recommended for people who have existing heart problems, since it is possible to raise the blood pressure and heart rate.
It is also not recommended for people with overactive thyroid, glaucoma, epilepsy, severe anxiety, and agitation, or those using MAO inhibitors within the past 2 weeks. These side effects are one of the reasons why Modafinil is being looked at as a newer drug to replace Adderall XR use.
Adderall Review:
Adderall is considered to be a highly effective drug in the short-term, but there are some very real side effects risks. You must speak to a health professional before using this drug and you should only take it on an occasional or as-needed basis. If you are not comfortable with the possible dangers associated with Adderall, another alternative would be to look at using nootropics for concentration and focus.
Many former Adderall users have found success with taking Noopept and Citicoline to boost their motivation, attention and energy levels. Not only are these supplements known to increase cognitive performance, memory and attention, they are also neuroprotective and support better brain health in the long term.
- Franke AG, Bagusat C, Rust S, Engel A, Lieb K. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci. 2014
- Fitzgerald KT, Bronstein AC. Adderall® (amphetamine-dextroamphetamine) toxicity. Top Companion Anim Med. 2013
- Steiner H, Van Waes V. Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants. Prog Neurobiol. 2013
- Varga MD. Adderall abuse on college campuses: a comprehensive literature review. J Evid Based Soc Work. 2012
- Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Ann Pharmacother. 2009
- Steinhoff KW. Special issues in the diagnosis and treatment of ADHD in adolescents. Postgrad Med. 2008
- Rostain AL. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med. 2008
- Weisler RH. Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD. Expert Opin Pharmacother. 2005
- Sallee FR, Smirnoff AV. Adderall XR: long acting stimulant for single daily dosing. Expert Rev Neurother. 2004
- Greenfield B, Hechman L. Treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother. 2005
- Horrigan JP. Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder. Expert Opin Pharmacother. 2001
- Pliszka SR. The use of psychostimulants in the pediatric patient. Pediatr Clin North Am. 1998
- Findling RL, Dogin JW. Psychopharmacology of ADHD: children and adolescents. J Clin Psychiatry. 1998
- [No authors listed] Adderall: the newest available option in ADHD. Adv Nurse Pract. 1997
- Veliz P, Boyd C, McCabe SE. Adolescent athletic participation and nonmedical Adderall use: an exploratory analysis of a performance-enhancing drug. J Stud Alcohol Drugs. 2013
- Hanson CL, Burton SH, Giraud-Carrier C, West JH, Barnes MD, Hansen B. Tweaking and tweeting: exploring Twitter for nonmedical use of a psychostimulant drug (Adderall) among college students. J Med Internet Res. 2013
- Narine C, Sarwar SR, Rais TB. Adderall-induced Trichotillomania: A Case Report. Innov Clin Neurosci. 2013
- Sharma J, de Castro C, Chatterjee P, Pinto R. Acute myocardial infarction induced by concurrent use of adderall and alcohol in an adolescent. Pediatr Emerg Care. 2013
- Vanga RR, Bal B, Olden KW. Adderall induced acute liver injury: a rare case and review of the literature. Case Rep Gastrointest Med. 2013
- Alsidawi S, Muth J, Wilkin J. Adderall induced inverted-Takotsubo cardiomyopathy. Catheter Cardiovasc Interv. 2011
- Hammerschlag C. Adderall in the land of Oz. Caring. 2013
- Flanigan J. Adderall for All: A Defense of Pediatric Neuroenhancement. HEC Forum. 2013
- Sylvester AL, Agarwala B. Acute myocardial infarction in a teenager due to Adderall XR. Pediatr Cardiol. 2012
- Rosenthal E. Not acute myocardial infarction in a teenager due to Adderall XR. Pediatr Cardiol. 2012
- Allen JK, Wilkinson M, Soo EC, Hui JP, Chase TD, Carrey N. Chronic low dose Adderall XR down-regulates cfos expression in infantile and prepubertal rat striatum and cortex. Neuroscience. 2010
- Gabriel A. The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study. Atten Defic Hyperact Disord. 2010
- Farah MJ, Haimm C, Sankoorikal G, Smith ME, Chatterjee A. When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study. Psychopharmacology (Berl). 2009
- DeSantis AD, Hane AC. Adderall is definitely not a drug": justifications for the illegal use of ADHD stimulants." Subst Use Misuse. 2010
- Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC. Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv. 2013
- Cassidy TA, Varughese S, Russo L, Budman SH, Eaton TA, Butler SF. Nonmedical Use and Diversion of ADHD Stimulants Among U.S. Adults Ages 18-49: A National Internet Survey. J Atten Disord. 2015
- Grcevich S, Rowane WA, Marcellino B, Sullivan-Hurst S. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001
- Pelham WE, Gnagy EM, Chronis AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL, Williams A, Aronoff HR, Steiner RL. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 1999
- Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics. 1999
- Ahmann PA, Theye FW, Berg R, Linquist AJ, Van Erem AJ, Campbell LR. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics. 2001
- Manos MJ, Short EJ, Findling RL. Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999
- Cassidy TA, McNaughton EC, Varughese S, Russo L, Zulueta M, Butler SF. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system. J Atten Disord. 2015
- Jiao X, Velez S, Ringstad J, Eyma V, Miller D, Bleiberg M. Myocardial infarction associated with adderall XR and alcohol use in a young man. J Am Board Fam Med. 2009
- Cody JT, Valtier S, Nelson SL. Amphetamine enantiomer excretion profile following administration of Adderall. J Anal Toxicol. 2003
- McGough JJ, Biederman J, Greenhill LL, McCracken JT, Spencer TJ, Posner K, Wigal S, Gornbein J, Tulloch S, Swanson JM. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry. 2003
- Swanson JM, Wigal S, Greenhill LL, Browne R, Waslik B, Lerner M, Williams L, Flynn D, Agler D, Crowley K, Fineberg E, Baren M, Cantwell DP. Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry. 1998
- Forrester MB. Adderall abuse in Texas, 1998-2004. J Toxicol Environ Health A. 2007
- Faraone SV, Pliszka SR, Olvera RL, Skolnik R, Biederman J. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a reanalysis using drug-placebo and drug-drug response curve methodology. J Child Adolesc Psychopharmacol. 2001
- Pliszka SR, Browne RG, Olvera RL, Wynne SK. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000
- Tulloch SJ, Zhang Y, McLean A, Wolf KN. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration. Pharmacotherapy. 2002
- Joyce BM, Glaser PE, Gerhardt GA. Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers. Psychopharmacology (Berl). 2007
- Greenhill LL, Swanson JM, Steinhoff K, Fried J, Posner K, Lerner M, Wigal S, Clausen SB, Zhang Y, Tulloch S. A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003
- Faraone SV, Biederman J, Roe C. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol. 2002
- Justice J, Kupiec TC, Matthews P, Cardona P. Stability of Adderall in extemporaneously compounded oral liquids. Am J Health Syst Pharm. 2001
- Cheng A, Tithecott GA, Edwards WE, Johnston IG. The impact of the withdrawal of Adderall XR (long-acting mixed amphetamine salts) from the Canadian market on paediatric patients and their families. Paediatr Child Health. 2007
- Pomeroy D. Re: Myocardial infarction associated with Adderall XR and alcohol use in a young man. J Am Board Fam Med. 2009
- Faraone SV, Short EJ, Biederman J, Findling RL, Roe C, Manos MJ. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. Int J Neuropsychopharmacol. 2002
- Ponizovsky AM, Marom E, Fitoussi I. Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005-2012. Pharmacoepidemiol Drug Saf. 2014
- Auiler JF, Liu K, Lynch JM, Gelotte CK. Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study. Curr Med Res Opin. 2002
- Faraone SV, Biederman J. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis. J Atten Disord. 2002
- Swanson J, Wigal S, Greenhill L, Browne R, Waslick B, Lerner M, Williams L, Flynn D, Agler D, Crowley KL, Fineberg E, Regino R, Baren M, Cantwell D. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharmacol Bull. 1998
- Wilcox A, Russell KE. Hematologic changes associated with Adderall toxicity in a dog. Vet Clin Pathol. 2008
- Sichilima T, Rieder MJ. Adderall and cardiovascular risk: A therapeutic dilemma. Paediatr Child Health. 2009
- McCracken JT, Biederman J, Greenhill LL, Swanson JM, McGough JJ, Spencer TJ, Posner K, Wigal S, Pataki C, Zhang Y, Tulloch S. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003
- McGough JJ, Biederman J, Wigal SB, Lopez FA, McCracken JT, Spencer T, Zhang Y, Tulloch SJ. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005
- Findling RL, Short EJ, Manos MJ. Short-term cardiovascular effects of methylphenidate and adderall. J Am Acad Child Adolesc Psychiatry. 2001
- Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL, Wigal TL, Kollins SH, Clark TM, Mays DA, Zhang Y, Tulloch SJ. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. J Atten Disord. 2005
- Owley T, Owley S, Leventhal B, Cook EH Jr. Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder. J Child Adolesc Psychopharmacol. 2002
- Jeffers AJ, Benotsch EG. Non-medical use of prescription stimulants for weight loss, disordered eating, and body image. Eat Behav. 2014
- Singh I, Bard I, Jackson J. Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One. 2014
- Dodge T, Williams KJ, Marzell M, Turrisi R. Judging cheaters: is substance misuse viewed similarly in the athletic and academic domains? Psychol Addict Behav. 2012
- Wigal SB, Swanson JM, Greenhill L, Waslick B, Cantwell D, Clevenger W, Davies M, Lerner M, Regino R, Fineberg E, Baren M, Browne R. Evaluation of individual subjects in the analog classroom setting: II. Effects of dose of amphetamine (Adderall). Psychopharmacol Bull. 1998
- Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002
- Marks DH. Cardiomyopathy due to ingestion of Adderall. Am J Ther. 2008
- Biron P, Mintzes B, Lexchin J. Questions about Adderall XR. CMAJ. 2006
- Gandhi PJ, Ezeala GU, Luyen TT, Tu TC, Tran MT. Myocardial infarction in an adolescent taking Adderall. Am J Health Syst Pharm. 2005
- González MA, Polli JE, Morgan JA. Comments on effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR food evaluation study. Curr Med Res Opin. 2002
- Diller LH. Adderall and the FDA. J Am Acad Child Adolesc Psychiatry. 2001
- Diller LH. Assessment of Adderall in ADHD. J Am Acad Child Adolesc Psychiatry. 1999
- [No authors listed] Adderall and other drugs for attention-deficit/hyperactivity disorder. Med Lett Drugs Ther. 1994
- Kondro W. Inconclusive evidence puts Adderall back on the market. CMAJ. 2005
- [No authors listed] Adderall. Med Lett Drugs Ther. 2005
- Surles LK, May HJ, Garry JP. Adderall-induced psychosis in an adolescent. J Am Board Fam Pract. 2002
- Thomas S, Upadhyaya H. Adderall and seizures. J Am Acad Child Adolesc Psychiatry. 2002
- Horrigan JP, Barnhill LJ, Kohli RR. Adderall, the atypicals, and weight gain. J Am Acad Child Adolesc Psychiatry. 2001
- Albucher RC, Curtis GC. Adderall for obsessive-compulsive disorder. Am J Psychiatry. 2001
- Kalikow KT, Blumencranz H. Severe weight loss induced by Adderall in a child with ADHD. J Child Adolesc Psychopharmacol. 1996
- Moore DR, Burgard DA, Larson RG, Ferm M. Psychostimulant use among college students during periods of high and low stress: an interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addict Behav. 2014
- Faraone SV, Wigal SB, Hodgkins P. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD. J Atten Disord. 2007
- McKeage K, Scott LJ. SLI-381 (Adderall XR). CNS Drugs. 2003
- Burgard DA, Fuller R, Becker B, Ferrell R, Dinglasan-Panlilio MJ. Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: wastewater analysis of amphetamine and ritalinic acid. Sci Total Environ. 2013
- Dubljevi? V. Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults. Am J Bioeth. 2013
- Ilieva I, Boland J, Farah MJ. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology. 2013
- Grcevich S. Review: adderall may have a small advantage over methylphenidate in attention deficit hyperactivity disorder. Evid Based Ment Health. 2003
- Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group,... Clin Ther. 2006
- Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006
- Eggertson L. US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada. CMAJ. 2005
- Ilieva IP, Farah MJ. Enhancement stimulants: perceived motivational and cognitive advantages. Front Neurosci. 2013
- Vrecko S. Everyday drug diversions: a qualitative study of the illicit exchange and non-medical use of prescription stimulants on a university campus. Soc Sci Med. 2015
- Rasmussen N. Amphetamine-Type Stimulants: The Early History of Their Medical and Non-Medical Uses. Int Rev Neurobiol. 2015
- Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2000
- Brandt SA, Taverna EC, Hallock RM. A survey of nonmedical use of tranquilizers, stimulants, and pain relievers among college students: patterns of use among users and factors related to abstinence in non-users. Drug Alcohol Depend. 2014
- Spencer T, Biederman J, Wilens T, Faraone S, Prince J, Gerard K, Doyle R, Parekh A, Kagan J, Bearman SK. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001
- Ott R, Biller-Andorno N. Neuroenhancement among Swiss students--a comparison of users and non-users. Pharmacopsychiatry. 2014
- McNiel AD, Muzzin KB, DeWald JP, McCann AL, Schneiderman ED, Scofield J, Campbell PR. The nonmedical use of prescription stimulants among dental and dental hygiene students. J Dent Educ. 2011
- McCabe SE, West BT. Medical and nonmedical use of prescription stimulants: results from a national multicohort study. J Am Acad Child Adolesc Psychiatry. 2013
- Jardin B, Looby A, Earleywine M. Characteristics of college students with attention-deficit hyperactivity disorder symptoms who misuse their medications. J Am Coll Health. 2011
- Lakhan SE, Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav. 2012
- Ford JB, Albertson TE, Owen KP, Sutter ME, McKinney WB. Acute, sustained chorea in children after supratherapeutic dosing of amphetamine-derived medications. Pediatr Neurol. 2012
- Howland RH. The use of dopaminergic and stimulant drugs for the treatment of depression. J Psychosoc Nurs Ment Health Serv. 2012
- Cody JT, Valtier S, Nelson SL. Amphetamine excretion profile following multidose administration of mixed salt amphetamine preparation. J Anal Toxicol. 2004
- Marchetti A, Magar R, Lau H, Murphy EL, Jensen PS, Conners CK, Findling R, Wineburg E, Carotenuto I, Einarson TR, Iskedjian M. Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis. Clin Ther. 2001
- Hechtman L. Treatment of ADHD in patients unresponsive to methylphenidate. J Psychiatry Neurosci. 2011
- James RS, Sharp WS, Bastain TM, Lee PP, Walter JM, Czarnolewski M, Castellanos FX. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J Am Acad Child Adolesc Psychiatry. 2001
- Herman L, Shtayermman O, Aksnes B, Anzalone M, Cormerais A, Liodice C. The use of prescription stimulants to enhance academic performance among college students in health care programs. J Physician Assist Educ. 2011
- Carrey N, Wilkinson M. A review of psychostimulant-induced neuroadaptation in developing animals. Neurosci Bull. 2011
- Grcevich S. SLI381: a long-acting psychostimulant preparation for the treatment of attention-deficit hyperactivity disorder. Expert Opin Investig Drugs. 2001
Article last updated on: March 13th, 2018 by Nootriment